©The Author(s) 2025.
World J Gastrointest Oncol. Sep 15, 2025; 17(9): 106912
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106912
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.106912
Table 3 Comparison of data of two groups of scales, mean ± SD
| Characteristic | PD with gastrointestinal tumours | The PD was not accompanied by gastrointestinal tumors (n = 64) | t/χ2 | P value |
| MMSE | 15.33 ± 1.48 | 15.64 ± 1.33 | 0.815 | 0.417 |
| DASS-21 | 37.81 ± 2.08 | 38.02 ± 2.14 | 0.353 | 0.725 |
| PSQI | 18.42 ± 1.26 | 18.21 ± 1.33 | 0.571 | 0.570 |
| BI | 31.16 ± 2.43 | 30.97 ± 2.24 | 0.298 | 0.766 |
| NMSS | 60.51 ± 3.29 | 43.59 ± 3.99 | 15.661 | < 0.001 |
| I-FEED | 10.49 ± 1.56 | 4.65 ± 1.11 | 17.273 | < 0.001 |
- Citation: Fu ZG, Ren ZX, Wang XH, Wang BF. Investigation of gastrointestinal tumor symptoms and risk factors in eighty patients with Parkinson’s disease. World J Gastrointest Oncol 2025; 17(9): 106912
- URL: https://www.wjgnet.com/1948-5204/full/v17/i9/106912.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.106912